Journal profile

British journal of clinical pharmacology

Publisher: Wiley-Blackwell
ISSN0306-5251 | 1365-2125 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.76
Citation rate 3.07 2,191 total citations
h5-index 52 h5 depth signal
Cited share 72.6% 540 of 744
Total citations 2,191 Citation footprint
Metric signal 3.29 External metric anchor
Self-citation 6.4% 141 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 822
United Kingdom 821
Netherlands 601
Australia 420
China 383

Citing Fields of Research

Pharmacology & Toxicology 1,098
Medical Ethics 485
Cardiology 461
Patient Care 438
Cancer Drugs 283

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 13,647 Articles tracked across the journal lifetime
Indexed publication set 744 540 cited publications
Last 12 months 540 45.0 publications/month
Open access share 54.1% 292 OA publications in the last year
Leading citing country United States 822 citing publications
Leading citing field Pharmacology & Toxicology 1,098 citing publications
Latest tracked publication 18 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v2n2,Feb. 1975-
PubMed
v1, 1974-
PMC Inactive
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Pharmacology & Toxicology Patient Care HIV Cardiology Medical Ethics Antibiotic & Antibacterial Agents

Issuing & Sponsoring Bodies

Contributor
British Pharmacological Society

Broad Categories

Pharmacology Medical Ethics Patient Care Antibiotic & Antibacterial Agents HIV Cardiology Pharmacology & Toxicology Anesthetic & Pain Medicine

MeSH Descriptors

Pharmaceutical Preparations Pharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Stanley O. Onyegbule, Maryam Habib, Rija Khalid et al.
Background: We conducted a systematic review of clinical trials and cohort studies on HIV post‐exposure prophylaxis (PEP) regimens to inform updated 2025 Canadian guidelines. Methods: We searched Medline and Embase (July 2017–June 2024) ...
08
Misako Takenaka, Scott Marshall, Frances Stringer et al.
Aims: Population pharmacokinetic (popPK) modelling is widely used to support paediatric dose optimization, yet consensus on appropriate modelling approaches remains limited. This study compared pooled and Bayesian popPK approaches for pa...
09
Lachlan L. Dalli, Susie Cartledge, Caroline Trin et al.
Limited evidence exists on how patients with cardiovascular disease (CVD) prefer to receive medicines information and whether having unmet needs influences medication adherence. We conducted a cross‐sectional study using national survey ...
10
Ryan Jayesinghe, Amandeep Khatter, Stevo Durbaba et al.
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Me...

Bibliographical & Catalog Notes

Edited for the British Pharmacological Society.

Print issues ceased with v. 74, no. 6 (2012).

Supplements accompany some vols.

Also issued online.

Vol. 31, no. 1 (JAN 1991)19910912 Notice published Printed on acid-free paper

Will not microfilm 2005225